Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Ultrapar Participações S.A.UGP: This energy and infrastructure company has seen the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.
Ultrapar Participacoes S.A. Price and Consensus
Ultrapar Participacoes S.A. price-consensus-chart | Ultrapar Participacoes S.A. Quote
ScanSource, Inc.SCSC: This technology distribution company has seen the Zacks Consensus Estimate for its current year earnings increasing 11.9% over the last 60 days.
ScanSource, Inc. Price and Consensus
ScanSource, Inc. price-consensus-chart | ScanSource, Inc. Quote
Marker Therapeutics, Inc.MRKR: This clinical-stage immuno-oncology company has seen the Zacks Consensus Estimate for its current year earnings increasing 13.5% over the last 60 days.
MARKER THERAPEUTICS, INC. Price and Consensus
MARKER THERAPEUTICS, INC. price-consensus-chart | MARKER THERAPEUTICS, INC. Quote
Sol-Gel Technologies Ltd.SLGL: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 30.6% over the last 60 days.
Sol-Gel Technologies Ltd. Price and Consensus
Sol-Gel Technologies Ltd. price-consensus-chart | Sol-Gel Technologies Ltd. Quote
Methanex CorporationMEOH: This chemical manufacturing company has seen the Zacks Consensus Estimate for its current year earnings increasing 3.5% over the last 60 days.
Methanex Corporation Price and Consensus
Methanex Corporation price-consensus-chart | Methanex Corporation Quote
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Methanex Corporation (MEOH) : Free Stock Analysis Report
ScanSource, Inc. (SCSC) : Free Stock Analysis Report
Ultrapar Participacoes S.A. (UGP) : Free Stock Analysis Report
Sol-Gel Technologies Ltd. (SLGL) : Free Stock Analysis Report
MARKER THERAPEUTICS, INC. (MRKR) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
